Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis

二维码有效期 120s

作者 Zhao Chenyang ^[1] Cui Zhao ^[1] Zhang Yimiao ^[1] Wang Fang ^[1] Wang Xin ^[1] Cheng Xuyang ^[1] Meng Liqiang ^[1] Liu Gang ^[1] Zhao Minghui ^[1] 学术成果认领

作者单位 Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University; Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China, Beijing 100034, China ^[1]

栏目名称 Correspondence

DOI 10.1097/CM9.0000000000001855

发布时间 2025-02-25

基金项目

Natural Science Foundation of China

浏览38
被引0
下载0

中华医学杂志英文版

2022年135卷7期

866-868页

SCIMEDLINEISTICCSCDCABP

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis

Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis

中华医学杂志英文版

相似文献

中华医学杂志英文版

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis

Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis

中华医学杂志英文版

相似文献

中华医学杂志英文版

相关期刊

检索历史清除